Tirzepatide

Tax included
Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes.
MedChemExpress 
HY-P1731

Data sheet

Size
Multiple sizes
Reactivity
GCGR
Application
Metabolism-sugar/lipid metabolism
CAS
2023788-19-2